Alazraki, N. P., Krawczynska, E. G., Kosinski, A. S., Ziffer, J. A., DePuey, E. G., Taylor, A. T., … King, S. B. (1996). Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST). JOURNAL OF NUCLEAR MEDICINE, 37(5), 492–492.

Alazraki, N. P., E. G. Krawczynska, A. S. Kosinski, J. A. Ziffer, E. G. DePuey, A. T. Taylor, J. P. Vansant, R. I. Pettigrew, W. S. Weintraub, and S. B. King. “Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST).” JOURNAL OF NUCLEAR MEDICINE 37, no. 5 (May 1, 1996): 492–492.

Alazraki NP, Krawczynska EG, Kosinski AS, Ziffer JA, DePuey EG, Taylor AT, et al. Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST). JOURNAL OF NUCLEAR MEDICINE. 1996 May 1;37(5):492–492.

Alazraki, N. P., et al. “Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST).” JOURNAL OF NUCLEAR MEDICINE, vol. 37, no. 5, SOC NUCLEAR MEDICINE INC, May 1996, pp. 492–492.

Alazraki NP, Krawczynska EG, Kosinski AS, Ziffer JA, DePuey EG, Taylor AT, Vansant JP, Pettigrew RI, Weintraub WS, King SB. Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST). JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 1996 May 1;37(5):492–492.